Partnership between Artialis & Regulaxis!

Regulaxis (France) chooses Artialis Group for the development of its new treatment against osteoarthritis!

Published on 25/06/2018

Paris, France and Liege, Belgium [June 25], 2018: Artialis, specialist in the study of the musculoskeletal disorders and Regulaxis, an innovative French company in the treatment of osteoarthritis, announce today the signing of a 1.6 million euros contract for the preclinical and clinical development of a new molecule, Reg-O3, allowing the repair of cartilage.

Regulaxis-Artialis.png

 © Artialis - All rights reserved
Terms & conditions - Privacy Policy